Natural History of Individuals With Immune System Problems That Lead to Fungal Infections
NCT01386437 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200
Last updated 2026-05-22
Summary
Background:
\- The immune system is made up of special cells, tissues, and organs that fight infections. Problems with this system may lead to frequent, severe, or unusual fungal infections. These infections are often difficult to treat. Researchers want to collect blood and tissue samples from people who have unusual, persistent or severe fungal infections or immune problems that increase the risk of these infections.
Objectives:
\- To collect medical information and samples for a long-term study of people with immune system problems that lead to fungal infections.
Eligibility:
* People with a history of fungal infections caused by immune system problems.
* Parents, children, and siblings of this group.
* Healthy volunteers not related to the first two groups.
Design:
* This long-term study may last for up to 25 years. Those in the study may need to provide new information about every 6 months. The procedures for each person may vary with the particular diagnosis and the extent of fungal infection. Healthy volunteers may have only one or two visits.
* At the first visit, those in the study will have a full medical history and physical exam. They will also provide blood.
* Research procedures may include the following:
* Saliva, urine or stool testing
* Mouthwash collection for DNA testing
* Collection of cheek cells, nail clippings, or vaginal fluid
* Tests of leftover tissue or body fluid from previous medical procedures
* Skin or oral mucous membrane biopsy
* Collection of white blood cells
* Followup visits will involve a physical exam and updated medical history. Blood, saliva, urine, or nail clipping samples may be taken for ongoing studies. Any additional tests or exams required by the study doctors may also be done.
* Participants may withdraw from the study pool at any time....
Conditions
- Chronic Mucocutaneous Candidiasis
- Invasive Aspergillosis
- CARD9
- APECED
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Michail S Lionakis, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility
- Min Age
- 1 Day
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-11-05
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection
NCT00001702 ·Status: COMPLETED
-
Retrospective Chart Review of Candida Fungemia
NCT03827330 ·Status: COMPLETED
-
Aspergillosis and Humoral Alveolar Immunity by Proteomics
NCT04728763 ·Status: UNKNOWN
-
Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
NCT01686607 ·Status: COMPLETED
-
ImPACt on Invasive Fungal Infections by Immune Checkpoint Inhibition
NCT04533087 ·Status: COMPLETED
-
Funguria in Hospitalized Patients
NCT00138502 ·Status: COMPLETED
-
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
NCT00001646 ·Status: COMPLETED ·Phase: PHASE3
-
Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections
NCT06387667 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
NCT00238355 ·Status: TERMINATED ·Phase: PHASE2
-
MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)
NCT00076869 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
NCT03262584 ·Status: COMPLETED
-
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
NCT00445952 ·Status: COMPLETED
-
Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection
NCT00001701 ·Status: COMPLETED
-
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment
NCT03059992 ·Status: COMPLETED ·Phase: PHASE3
-
Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
NCT00723073 ·Status: COMPLETED
-
Investigation of Clinical Relevance of β-D-Glucan Tests in Patients With Invasive Fungal Infection (IFI)
NCT01490138 ·Status: UNKNOWN
-
The Assessment of Antimicrobial Peptides Against Fungal Infection
NCT05368948 ·Status: UNKNOWN
-
Microbiota in Skin and Mucosa of Patients With Inflammatory Skin Diseases
NCT04215458 ·Status: UNKNOWN ·Phase: NA
-
A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections
NCT00002277 ·Status: COMPLETED ·Phase: PHASE3
-
Micafungin Salvage Mono-therapy in Invasive Aspergillosis
NCT00376337 ·Status: TERMINATED ·Phase: PHASE2
-
Interest of Real-time Polymerase Chain Reaction (PCR) in the Diagnosis of Fungal Infections
NCT00876096 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
NCT00004938 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
NCT05235711 ·Status: COMPLETED
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease
NCT00001280 ·Status: COMPLETED ·Phase: PHASE2